Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from LTR Pharma Limited ( (AU:LTP) ) is now available.
LTR Pharma Limited has issued an investor update presentation intended solely as general information about the company and its activities. The document emphasises that it is not a prospectus, does not constitute an offer or invitation to buy or sell securities, and should not be relied upon as financial product advice for investment decisions.
The company stresses that the material has not been independently verified, may be incomplete, and may change without notice, with no obligation to update. It also highlights the presence of forward-looking information subject to significant risks and uncertainties, and disclaims liability for any loss arising from reliance on the presentation.
More about LTR Pharma Limited
LTR Pharma Limited is an Australian specialty pharmaceutical company focused on building a portfolio of differentiated therapies. The company targets niche treatment areas where it can develop and commercialise proprietary products to address unmet medical needs and create value for investors in the healthcare sector.
Average Trading Volume: 292,771
Technical Sentiment Signal: Sell
Current Market Cap: A$79.07M
See more data about LTP stock on TipRanks’ Stock Analysis page.